Generalized Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Generalized Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis [Phase 1, Phase 2]
A Phase 1/2 clinical trial to assess safety, efficacy, and cellular kinetics of YTB323 in generalized myasthenia gravis is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis [Phase 3]
This is an update on a Phase 3 clinical trial evaluating the safety, PK/PD, and efficacy of Gefurulimab in pediatric patients with AChR-posi…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. [Phase 3]
A Phase III clinical trial evaluating iptacopan vs placebo for generalized myasthenia gravis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis [Phase 3]
Phase 3 study update on the safe and effective use of a zilucoplan auto-injector in adults with generalized myasthenia gravis; results have …
-
FDA approval · 2026-03-26FDA Approved: BKEMV — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for BKEMV (eculizumab-aeeB) from Amgen.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis [Phase 3]
Phase 3 study evaluating batoclimab for induction and maintenance therapy in adults with generalized myasthenia gravis. The trial is current…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) [Phase 3]
A Phase 3 clinical trial (UPSTREAM MG) is evaluating telitacicept for generalized myasthenia gravis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Zilucoplan for Severe gMG Exacerbations [Phase 3]
A Phase 3 clinical trial investigating Zilucoplan for severe exacerbations of Generalized Myasthenia Gravis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis [Phase 1, Phase 2]
This clinical trial update shows that Cabaletta Bio's experimental therapy CABA-201 is being evaluated in Phase 1/2 studies for generalized …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis [Phase 2, Phase 3]
A Phase 2/3 trial is evaluating intravenous efgartigimod in children with generalized myasthenia gravis. The study focuses on pharmacokineti…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
This clinical trial registry update describes a registry of participants with generalized myasthenia gravis treated with Alexion's C5 inhibi…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis [Phase 3]
A Phase 3 clinical trial update evaluating safety and efficacy of Pozelimab with Cemdisiran combination and Cemdisiran alone in adults with …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
This clinical trial update shows that ravulizumab is being studied as early treatment for anti-AChR antibody-positive generalized myasthenia…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited is conducting a clinical trial to detect fatigue from voice in generalized myasthenia gravis; the study status is NOT_YET_REC…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 long-term safety and tolerability results for subcutaneous efgartigimod PH20 in Generalized Myasthenia Gravis have been reported.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG [Phase 3]
Phase 3 study evaluating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of eculizumab in Chinese adults with g…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis [Phase 2, Phase 3]
A pediatric Phase 2/3 study evaluating subcutaneous efgartigimod alfa-ph20 for generalized myasthenia gravis in children aged 2 to under 18 …
-
FDA approval · 2025-11-24FDA Approved: BKEMV — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for BKEMV (eculizumab-aeeB) from Amgen, a biosimilar to eculizumab.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) [Phase 1]
A phase 1 clinical trial update shows that Candid Therapeutics is conducting a Phase 1 study of Cizutamig for Generalized Myasthenia Gravis,…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis [Phase 3]
An open-label Phase 3 study evaluating different dosing regimens of efgartigimod IV in generalized myasthenia gravis has been completed.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis [Phase 3]
Clinical trial update for a Phase 3 study evaluating intravenous efgartigimod in acetylcholine receptor antibody seronegative generalized my…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) [EARLY_Phase 1]
This clinical trial update reports on a Phase 1 study of GC012F Injection for refractory generalized myasthenia gravis, with the study curre…
-
FDA approval · 2025-09-02FDA Approved: EPYSQLI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for EPYSQLI (eculizumab-aagh) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: An Exploratory Clinical Study of GC012F Injection for Refractory gMG [EARLY_Phase 1]
An exploratory early-phase study evaluating GC012F injection for refractory generalized myasthenia gravis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of tocilizumab in generalized myasthenia gravis, currently recruiting.